Cell transformation results in the loss of the density-dependent translational regulation of the expression of fibroblast growth factor 2 isoforms

Cancer Research

Volumn 59, Issue 1, 1999, Pages 165-171

  Galy, Bruno ^a   Maret, Arlette ^a   Prats, Anne Catherine ^a   Prats, Hervé ^a  

^a CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RNA;

ARTICLE; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CELL TRANSFORMATION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; START CODON; TRANSLATION REGULATION; TUMOR GROWTH;

ANIMALS; CELL COUNT; CELL TRANSFORMATION, NEOPLASTIC; COS CELLS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; TUMOR CELLS, CULTURED;

EID: 0032944323     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Couderc, B., Prats, H., Bayard, F., and Amalric, F. Potential oncogenic effects of basic fibroblast growth factor requires cooperation between CUG and AUG-initiated forms. Cell Regul., 2: 709-718, 1991.
2. Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66: 1095-1104, 1991.
3. Takahashi, J. A., Mori, H., Fukumoto, M., Igarashi, K., Jaye, M., Oda, Y., Kikuchi, H., and Hatanaka, M. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc. Natl. Acad. Sci. USA, 87: 5710-5714, 1990.
4. Takahashi, J. A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H., and Hatanaka, M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg., 76: 792-798, 1992.
5. Becker, D., Meier, C. B., and Herlyn, M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J., 8: 3685-3691, 1989.
6. Ensoli, B., Markham, P., Kao, V., Barillari, G., Fiorelli, V., Gendelman, R., Raffeld, M., Zon, G., and Gallo, R. C. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Invest., 94: 1736-1746, 1994.
7. Maret, A., Galy, B., Arnaud, E., Bayard, F., and Prats, H. Inhibition of fibroblast growth factor 2 expression by antisense RNA induced a loss of the transformed phenotype in a human hepatoma cell line. Cancer Res., 55: 5075-5079, 1995.
8. Morrison, R. S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem., 266: 728-734, 1991.
9. Wang, Y., and Becker, D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med., 3: 887-893, 1997.
10. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
11. Takahashi, J. A., Fukumoto, M., Kozai, Y., Ito, N., Oda, Y., Kikuchi, H., and Hatanaka, M. Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett., 288: 65-71, 1991.
12. Quarto, N., Talarico, D., Florkiewicz, R., and Rifkin, D. B. Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells. Cell Regul., 2: 699-708, 1991.
13. Bikfalvi, A., Klein, S., Pintucci, G., and Rifkin, D. B. Biological roles of fibroblast growth factor-2. Endocr. Rev., 18: 26-45, 1997.
14. Prats, H., Kaghad, M., Prats, A. C., Klagsbrun, M., Lélias, J. M., Liauzun, P., Chalon, P., Tauber, J. P., Amalric, F., Smith, J. A., and Capul, D. High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons. Proc. Natl. Acad. Sci. USA, 86: 1836-1840, 1989.
15. Mignatti, P., Morimoto, T., and Rifkin, D. B. Basic fibroblast growth factor (bFGF) released by single isolated cells stimulates their migration in an autocrine manner. Proc. Natl. Acad. Sci. USA. 88: 11007-11011, 1991.
16. Mignatti, P., Morimoto, T., and Rifkin, D. B. Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J. Cell Physiol., 151: 81-93, 1992.
17. Bugler, B., Amalric, F., and Prats, H. Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol. Cell. Biol., 11: 573-577, 1991.
18. Bikfalvi, A., Klein, S, Pintucci, G., Quarto, N., Mignatti, P., and Rifkin, D. B. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. J. Cell Biol., 129: 233-243, 1995.
19. Klein, S., Bikfalvi, A., Birkenmeier, T. M., Giancotti, F. G., and Rifkin, D. B. Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J. Biol. Chem., 271: 22583-22590, 1996.
20. Renko, M., Quarto, N., Morimoto, T., and Rifkin, D. B. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J. Cell. Physiol., 144: 108-114, 1990.
21. Coffin, J. D., Florkiewicz, R. Z., Neumann, J., Mort-Hopkins, T., Dorn, G. W., Lightfoot, P., German, R., Howles, P. N., Kier, A., O'Toole, B. A., Sasse, J., Gonzalez, A. N., Baird, A., and Doetschman, T. Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. Mol. Biol. Cell, 6: 1861-1873, 1995.
22. Stachowiak, M. K., Moffett, J., Joy, A., Puchacz, E., Florkiewicz, R., and Stachowiak, E. K. Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells. J. Cell Biol., 127: 203-223, 1994.
23. Vagner, S., Touriol, C., Galy, B., Audigier, S., Gensac, M. C., Amalric, F., Bayard, F., Prats, H., and Prats, A. C. Translation of CUG-but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells. J. Cell Biol., 135: 1391-1402, 1996.
24. Prats, A. C., Vagner, S., Prats, H., and Amalric, F. cis-acting elements involved in the alternative translation initiation process of human basic fibroblast growth factor. Mol. Cell. Biol., 12: 4796-4805, 1992.
25. Vagner, S., Gensac, M. C., Maret, A., Bayard, F., Amalric, F., Prats, H., and Prats, A. C. Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol. Cell. Biol., 15: 35-44, 1995.
26. Kozak, M. The scanning model for translation: an update. J. Cell. Biol., 108: 229-241, 1989.
27. Bernstein, J., Sella, O., Le, S. Y., and Elroy-Stein, O. PDGF2/c-cis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES). J. Biol. Chem., 272: 9356-9362, 1997.
28. Macejak, D. J., and Sarnow, P. Internal initiation of translation mediated by the 5′ leader of a cellular mRNA. Nature (Lond.), 353: 90-94, 1991.
29. Nanbru, C., Lafon, I., Audigier, S., Gensac, M. C., Vagner, S., Huez, G., and Prats, A. C. Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J. Biol. Chem., 272: 32061-32066, 1997.
30. Stoneley, M., Paulin, F. E., Le Quesne, J. P., Chappell, S. A., and Willis, A. E. C-Myc 5′ untranslated region contains an internal ribosome entry segment. Oncogene, 16: 423-428, 1998.
31. Borman, A., Howell, M. T., Patton, J. G., and Jackson, R. J. The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation. J. Gen. Virol., 74: 1775-1788, 1993.
32. Borovjagin, A., Pestova, T., and Shatsky, I. Pyrimidine tract binding protein strongly stimulates in vitro encephalomyocarditis virus RNA translation at the level of preinitiation complex formation. FEBS Lett., 351: 299-302, 1994.
33. Hellen, C. U. T., Witherell, G. W., Schmid, M., Shin, S. H., Pestova, T. V., Gil, A., and Wimmer, E. A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosome entry is identical to the nuclear pyrimidine tract-binding protein. Proc. Natl. Acad. Sci. USA, 90: 7642-7646, 1993.
34. Meerovitch, K., Pelletier, J., and Sonenberg, N. A cellular protein that binds to the 5′-noncoding region of poliovirus RNA: implications for internal translation initiation. Genes Dev., 3: 1026-1034, 1989.
35. Kevil, C., Carter, P., Hu, B., and DeBenedetti. A. Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene, 11: 2239-2348, 1995.
36. Jobin, C., and Gauthier, J. Differential effects of cell density on 5-lipoxygenase (5-LO), five-lipoxygenase-activating protein (FLAP) and interleukin-1 β (IL-1 β) expression in human neutrophils. Inflammation, 21: 235-250, 1997.
37. Koura, A. N., Liu, W., Kiladai, Y., Singh, R. K., Radinsky, R., and Ellis, L. M. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res., 56: 3891-3894, 1996.
38. Freidin, M., Dougherty, M., and Kessler, J. A. Cell density regulates neuropeptide Y expression in cultured sympathetic neurons. Brain Res., 615: 135-140, 1993.
39. Bost, L. M., and Hjelmeland, L. M. Cell density regulates differential production of bFGF transcripts. Growth Factors, 9: 195-203, 1993.
40. Bost, L. M., Aotaki-Keen, A. E., and Hjelmeland, L. M. Cellular adhesion regulates bFGF gene expression in human retinal pigment epithelial cells. Exp. Eye Res., 58: 545-552, 1994.
41. Murphy, P. R., Sato, R., Sato, Y., and Friesen, H. G. Fibroblast growth factor messenger ribonucleic acid expression in a human astrocytoma cell line: regulation by serum and cell density. Mol. Endocrinol., 2: 591-598, 1988.
42. Singh, R. K., Llansa, N., Bucana, C. D., Sanchez, R., Koura, A., and Fidler, I. J. Cell density-dependent regulation of basic fibroblast growth factor expression in human renal cell carcinoma cells Cell Growth Differ., 7: 397-404, 1996.
43. Moffett, J., Kratz, E., Florkiewicz, R., and Stachowiak, M. K. Promoter regions involved in density-dependent regulation of basic fibroblast growth factor gene expression in human astrocytic cells. Proc. Natl. Acad. Sci. USA, 93: 2470-2475, 1996.
44. Hann, S. R., Sloan-Brown, K., and Spotts, G. D. Translational activation of the non-AUG-initiated c-myc 1 protein at high cell densities due to methionine deprivation. Genes Dev., 6: 1229-1240, 1992.
45. Benoist, C., and Chambon, P. In vivo sequence requirements of the SV40 early promoter region. Nature (Lond.), 290: 304-310, 1981.
46. Lejbkowicz, F., Goyer, C., Darveau, A., Neron, S., Lemieux, R., and Sonenberg, N. A fraction of the mRNA 5′ cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc. Natl. Acad. Sci. USA, 89: 9612-9616, 1992.
47. Gingras, A. C., Svitkin, Y., Belsham, G. J., Pause, A., and Sonenberg, N. Activation of the translational suppressor 4E-BP1 following infection with encephalomyocarditis virus and poliovirus. Proc. Natl. Acad. Sci. USA, 93: 5578-5583, 1996.
48. Pelletier, J., and Sonenberg, N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature (Lond.), 334: 320-325. 1988.
49. Lazaris-Karatzas, A., Montine, K. S., and Sonenberg, N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap Nature (Lond.), 345: 544-547, 1990.
50. Kerekatte, V., Smiley, K., Hu, B., Smith, A., Gelder, F., and De Benedetti, A. The proto-oncogene/translation factor elF4E: a survey of its expression in breast carcinomas. Int. J. Cancer, 64: 27-31, 1995.
51. Lawrence, J. C., Jr., and Abraham, R. T. PHAS/4E-BPs as regulators of mRNA translation and cell proliferation. Trends Biochem. Sci., 22: 345-349, 1997.
52. Nathan, C. A., Carter, P., Liu, L., Li, B. D., Abreo, F., Tudor, A., Zimmer, S. G., and De Benedetti, A. Elevated expression of elF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene, 15: 1087-1094, 1997.
53. West, M. J., Sullivan, N. F., and Willis, A. E. Translational upregulation of the c-myc oncogene in Bloom's syndrome cell lines. Oncogene. 11: 2515-2524, 1995.